Latest News for: o21
Edit
O21 Mason et alPooled Cardiac Safety Oral (Sarepta Therapeutics Inc)
Public Technologies 10 Oct 2025
) Assessment of Cardiac Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy ... Murphy8; Christoph Wandel9; James Richardson5. Author affiliations. ... Hoffmann-La Roche Ltd, Basel, Switzerland. Background ... 1. Kieny P, et al.
- 1